Oguzhan Alagoz

Oguzhan Alagoz

University of Wisconsin-Madison

H-index: 46

North America-United States

About Oguzhan Alagoz

Oguzhan Alagoz, With an exceptional h-index of 46 and a recent h-index of 35 (since 2020), a distinguished researcher at University of Wisconsin-Madison, specializes in the field of healthcare analytics, operations research, health economics, medical decision making, outcomes research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model

Optimizing Patient Transitions to Skilled Nursing Facilities

Analysis of Breast Cancer Mortality in the US—1975 to 2019

Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force

MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)

Calibration and validation of the colorectal cancer and adenoma incidence and mortality (CRC-AIM) microsimulation model using deep neural networks

EE269 Cost-Effectiveness of Profile Omission of Local Adjuvant Radiotherapy (POLAR), A Novel Genomic Signature, after Breast Conserving Surgery for Women with Invasive Early …

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis

Oguzhan Alagoz Information

University

Position

Proctor & Gamble Bascom Professor

Citations(all)

7599

Citations(since 2020)

4103

Cited By

5104

hIndex(all)

46

hIndex(since 2020)

35

i10Index(all)

87

i10Index(since 2020)

76

Email

University Profile Page

Google Scholar

Oguzhan Alagoz Skills & Research Interests

healthcare analytics

operations research

health economics

medical decision making

outcomes research

Top articles of Oguzhan Alagoz

Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model

Value in Health

2024/3/1

Optimizing Patient Transitions to Skilled Nursing Facilities

IISE Transactions

2024/2/5

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

Analysis of Breast Cancer Mortality in the US—1975 to 2019

JAMA

2024/1/16

Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force

JAMA

2024

MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)

Value in Health

2023/12/1

Calibration and validation of the colorectal cancer and adenoma incidence and mortality (CRC-AIM) microsimulation model using deep neural networks

Medical Decision Making

2023/8

Vahab Vahdat
Vahab Vahdat

H-Index: 7

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

EE269 Cost-Effectiveness of Profile Omission of Local Adjuvant Radiotherapy (POLAR), A Novel Genomic Signature, after Breast Conserving Surgery for Women with Invasive Early …

Value in Health

2023/6/1

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis

2023/5

Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data

Plos one

2023/4/21

Nasia Safdar
Nasia Safdar

H-Index: 51

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

An indirect assessment of individual-level association between disease-free survival (DFS) and overall survival (OS) for resectable esophageal or gastroesophageal junction …

2023/2/1

Team science principles enhance cancer care delivery quality improvement: Interdisciplinary implementation of breast cancer screening shared decision making

JCO Oncology Practice

2023/1

Amy Trentham-Dietz
Amy Trentham-Dietz

H-Index: 40

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

Personalized disease screening decisions considering a chronic condition

Management Science

2023/1

Ali Hajjar
Ali Hajjar

H-Index: 2

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

MSR38 Can Logistic Regression (LOR) Better Predict the Significance of the Overall Survival (OS) from Surrogate Endpoints (SES) for Randomized Controlled Trials (RCTS) in …

Value in Health

2022/12/1

Diagnostic accuracy of fine-needle biopsy in the detection of thyroid malignancy: a systematic review and meta-analysis

2022/12/1

Prevalence of subclinical papillary thyroid cancer by age: meta-analysis of autopsy studies

2022/10/1

Optimal breast cancer risk reduction policies tailored to personal risk level

Health care management science

2022/9

Ali Hajjar
Ali Hajjar

H-Index: 2

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

MSR12 Eliciting Unreported Subgroup-Specific Survival in Randomized Controlled Trials (RCTS): A Non-Parametric Linear Optimization Approach

Value in Health

2022/7/1

P-56 Estimating endpoint correlation between surrogate measures and overall survival using reconstructed survival data: Case studies from adjuvant and metastatic gastric cancer …

Annals of Oncology

2022/6/1

A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis

Production and Operations Management

2022/5

Oguzhan Alagoz
Oguzhan Alagoz

H-Index: 34

See List of Professors in Oguzhan Alagoz University(University of Wisconsin-Madison)

Co-Authors

academic-engine